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We congratulate the authors on their extension of the uni-
variate Egger test for publication bias to the multivariate
setting. The proposed Multivariate Small Study Effect Test
(MSSET) raises some interesting questions.
First, it is difficult to interpret the hypothesis that is
being tested, which is essentially asymmetry in one or
more of the funnel plots. This conflates two separate issues:
publication bias and outcome reporting bias. Strictly, pub-
lication bias means that—because of their results—some
papers are not published at all. Probably it is the primary
outcome that triggers this. We doubt this will lead to asym-
metry in the funnel plots for each outcome. If this is the
case, a multivariate test may provide misleading reassur-
ance compared to well-performing univariate test on the
primary outcome of the meta-analysis.
On the other hand, outcome reporting bias means that,
perhaps in response to the trial results, the authors switch
the primary and secondary outcomes around. The conse-
quence is the increased chance of suppression of some out-
comes in the publication. But again, it is not clear that this
will work in a way that causes a multivariate test to be nec-
essarily more informative than a well-performing univari-
ate test on the primary outcome of the meta-analysis. The
authors mention this obliquely, but it would be interesting
if they could respond this key point in more detail.
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Second the authors’ approach is essentially a score test
variant of performing multiple Egger tests in one step
using Generalized Estimating Equations, assuming inde-
pendence across outcomes for estimation, andusing robust
standard errors (clustered on studies). Looking at it in this
way explains how it avoids specification of the correlation,
but how much power does it really gain over univariate
analysis? Instinct suggests that without knowledge of the
correlation between the outcomes—an issue that limits the
practical utility of multivariate meta-analysis ((Riley et al.,
2017, table 1))—the answer would be little. Although the
simulation results suggest quite the reverse, it is unclear
whether the results presented can be taken at face value.
Ideally, we would like to see results from both univari-
ate and bivariate tests when the correlation is zero (these
should have the same power and type-1 error) and then, as
the correlation increases, it would be interesting to see how
the results from the two approaches diverge. Instead, the
authors’ Table 1 appears to average over the correlation (the
key parameter!) in some way that is not described. Then,
even in the case of independent outcomes, we appear to be
comparing naive application of the Egger test (with known
issues of type-1 error) with a corrected sampling distribu-
tion for the score test. So, definitive conclusions about the
greater power of the new test cannot be drawn. This is
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especially the case when we remember that if the type-1
error of a test is too small, the power is reduced (and vice
versa). For this reason, we and others (Rücker et al. (2011))
have argued this should be adjusted for before presenting
the results. In addition, presenting results of a Bonferroni
correction is a strawman: it is well known that Bonferroni-
Holm (Holm, 1979) is uniformly better.
The R code provided by the authors to conduct the
MSSET is welcome. Unfortunately, though it is not pos-
sible to reproduce the MSSET results of the heart fail-
ure meta-analysis because key information is omitted. We
assume that the (incomplete) reference in the publication
refers to a Heart editorial by Inglis et al. (2017), which
was published online in 2016. This editorial summarizing
results of a Cochrane review by Inglis et al. (2015) reports
two separate meta-analyses for the primary outcome “all-
cause mortality”: structured telephone support (STS) ver-
sus usual care (UC) in 22 trials and telemonitoring (TM)
versus UC with 17 trials, respectively. As two trials com-
pared both STS and TM with UC, the number of inde-
pendent studies providing data on the primary outcome is
37, which differs from the 34 trials reported here. Further-
more, the Cochrane review only provides qualitative infor-
mation on the secondary outcome “health-related quality
of life” ((Inglis et al., 2015, table 2)). Also, did the authors
follow Inglis et al. in using the risk ratio as a summary?
These uncertainties underscore the importance of provid-
ing both the analysis code and data sets in order to ensure
reproducible research.
Further, it remains unclear whether the comparison of
the univariate and bivariate P-values in the heart failure
meta-analysis is sensible, because it is not clear whether
the number of trials used in the univariate and bivariate
comparisons is the same. Specifically, the authors do not
state whether the univariate P-values are based on the 34
(all-cause mortality) and 12 (mental QoL) trials, or for the
11 trials providing data for both outcomes. In general, and
almost certainly in this situation too, the results will be
highly dependent on this. Also, we are unsure about the
appropriate analysis in this setting. We could envision that
a univariate test for funnel plot asymmetry is (a) significant
for an outcome in the smaller set of trials providing data for
both outcomes, however, (b) non-significant in the larger
set of trials providing data for the outcome of interest. This
goes back to our initial concern about the actual hypothe-
ses being tested.
Turning to the empirical evaluation in §4.2, the authors
state the following requirements for inclusion of a
Cochrane review in the evaluation: (a) at least 10 studies in
meta-analysis; (ii) common set of two outcomes, and (iii)
at least one study should report both outcomes. If correct,
this means that𝑚 = 1 is possible. But how do you conduct
a multivariate meta-analysis in this situation?
Although we welcome the authors’ provision of R code,
readers should perhaps be aware this is for bivariate anal-
yses only, not general multivariate analyses.
In summary, while we appreciated the opportunity to
read this paper:
∙ we are not clear about the interpretation of the test;
∙ the simulation study is limited to the bivariate situation,
and its reporting means that the behavior of the text viz-
a-viz the correlation parameter is obscured, and
∙ details of the data analysis leave some key questions
unanswered.
We encourage the authors to address these concerns,
which we argue need to be resolved for the community to
incorporate this methodology into practice.
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